Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

BDTX holding history

Black Diamond Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BDTX overviewAll 13F holders of BDTXFull Q2 2026 holdings

Shares (Q2 2026)
265,313
Value
$490.8K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of BDTX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026265,313$490.8K<0.1%−299,525−53.0%ReducedHolders
Q1 2026564,838$1.20M<0.1%+307,205+119.2%AddedHolders
Q4 2025257,633$626.0K<0.1%−370,783−59.0%ReducedHolders
Q3 2025628,416$2.38M<0.1%+314,716+100.3%AddedHolders
Q2 2025313,700$778.0K<0.1%+185,906+145.5%AddedHolders
Q1 2025127,794$198.1K<0.1%+77,901+156.1%AddedHolders
Q4 202449,893$106.8K<0.1%+11,436+29.7%AddedHolders
Q3 202438,457$167.3K<0.1%+11,923+44.9%AddedHolders
Q2 202426,534$123.6K<0.1%+22,263+521.3%AddedHolders
Q1 20244,271$21.7K<0.1%+284+7.1%AddedHolders
Q4 20233,987$11.2K<0.1%+3,741+1,520.7%AddedHolders
Q3 2023246$706<0.1%−8,273−97.1%ReducedHolders
Q2 20238,519$43.0K<0.1%+8,519NewHolders
Q1 20230$00.0%−3,433−100.0%Sold outHolders
Q4 20223,433$6.18K<0.1%−1,942−36.1%ReducedHolders
Q3 20225,375$9.00K<0.1%−12,224−69.5%ReducedHolders
Q2 202217,599$44.0K<0.1%−3,221−15.5%ReducedHolders
Q1 202220,820$58.0K<0.1%−8,734−29.6%ReducedHolders
Q4 202129,554$157.0K<0.1%+12,733+75.7%AddedHolders
Q3 202116,821$143.0K<0.1%+5,454+48.0%AddedHolders
Q2 202111,367$139.0K<0.1%−31,822−73.7%ReducedHolders
Q1 202143,189$1.05M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.